Print This PageBoard of Directors
Brief Biographies
- Frank V. AtLee, III
- John W. Bachmann
- David L. Chicoine
- Janice L. Fields
- Hugh Grant
- Arthur H. Harper
- Gwendolyn S. King
- C. Steven McMillan
- William U. Parfet
- George H. Poste, Ph. D., D.V.M.
- Robert J. Stevens
(Note: Ages as of February 1, 2010)
Frank V. AtLee III, 69, is a retired president of the former American Cyanamid Company and chairman of the former Cyanamid International. Both companies were involved in the discovery, development, manufacturing and marketing of medical and agricultural products. Mr. AtLee served Monsanto as chairman of the board and chair of the Executive Committee from June 2000 to October 2003. He was Monsanto’s interim president and chief executive officer from December 2002 to May 2003. He is a member of the Audit and Finance Committee and the Science and Technology Committee.
Mr. AtLee has been elected to a term that expires in 2013.
John W. Bachmann, 71, is a senior partner of Edward Jones, a major financial services firm that advises individual investors. From 1980 until 2004, Mr. Bachmann served as managing partner of Edward Jones. Mr. Bachmann was elected to the Monsanto board in May 2004 and is a member of the Audit and Finance Committee and the People and Compensation Committee. He also serves on the boards of AMR Corporation and the U.S. Chamber of Commerce, where he was the chairman of the board for 2004-2005.
Mr. Bachmann has been elected to a term that expires in 2011.
David L. Chicoine, Ph.D., 62, is president of South Dakota State University, a leading land-grant institution, and professor of economics. Prior to 2007, he was professor of agricultural economics at the University of Illinois at Urbana-Champaign and held various positions of increasing administrative responsibility with the University of Illinois, most recently as vice president for technology and economic development. Dr. Chicoine was elected to the Monsanto board in April 2009 and is a member of the Public Policy and Corporate Responsibility Committee and of the Science and Technology Committee.
Dr. Chicoine has been elected to a term that expires in 2013.
Janice L. Fields, 54, is president of McDonald’s USA, LLC, a subsidiary of McDonald’s Corporation, the world’s leading global foodservice retailer. She served as executive vice president and chief operating officer, McDonald’s USA from 2006 to 2010, and became president in January 2010. Her career with McDonald’s USA spans more than 30 years. Ms. Fields was elected to the Monsanto board in April 2008 and is a member of the Nominating and Corporate Governance Committee, the Public Policy and Corporate Responsibility Committee and of the Science and Technology Committee.
Ms. Fields has been elected to a term that expires in 2012.
Hugh Grant, 51, is chairman of the board, president and chief executive officer of Monsanto. He joined the former Monsanto as a product development representative for the company’s agricultural business in 1981. Since 1991, he has held a variety of management positions, most recently executive vice president and chief operating officer. Mr. Grant chairs the Executive Committee. He also serves on the board of PPG Industries, Inc. He has lived and worked in a number of international locations including Asia and Europe, as well as the United States.
Mr. Grant has been elected to a term that expires in 2012.
Arthur H. Harper, 54, is managing partner of GenNx360 Capital Partners, a private equity firm focused on business-to-business companies. He served as president and chief executive officer — Equipment Services Division, General Electric Corporation from 2002 to 2005 and executive vice president — GE Capital Services, General Electric Corporation from 2001 to 2002. Mr. Harper was elected to the Monsanto board in October 2006 and is a member of the Public Policy and Corporate Responsibility Committee and the Science and Technology Committee. He also serves on the board of Gannett Co., Inc.
Mr. Harper has been elected to a term that expires in 2013.
Gwendolyn S. King, 69, is president of Podium Prose, a speakers bureau. From 1992 to her retirement in 1998, Mrs. King was senior vice president, corporate and public affairs, for PECO Energy Company, now Exelon, a diversified utility company. From 1989 through 1992, Mrs. King served as the 11th Commissioner of Social Security. Prior to her appointment, she was deputy assistant to the president and director of Intergovernmental Affairs for President Ronald Reagan. Mrs. King has served as a director on the Monsanto board since February 2001. She chairs the board’s Public Policy and Corporate Responsibility Committee, and she is a member of the People and Compensation Committee and the Nominating and Corporate Governance Committee. Mrs. King also serves on the boards of Lockheed Martin Corporation and Marsh and McLennan Companies Inc.
Mrs. King has been elected to a term that expires in 2013.
C. Steven McMillan, 64, is a retired chairman of the board and chief executive officer of Sara Lee Corporation, a global consumer packaged goods company whose brands include Sara Lee, Hillshire Farm, Earth Grains, Jimmy Dean and Douwe Egberts. He has served as a director on the Monsanto board since June 2000. Mr. McMillan chairs the board's People and Compensation Committee, and he is a member of the Audit and Finance Committee and of the Nominating and Corporate Governance Committee.
Mr. McMillan has been elected to a term that expires in 2012.
William U. Parfet, 63, is chairman of the board and chief executive officer of MPI Research Inc., a preclinical toxicology research laboratory. He has served as a director on the Monsanto board since June 2000. Mr. Parfet chairs the board's Audit and Finance Committee, and he is a member of the People and Compensation Committee and the Executive Committee. He also serves on the boards of Stryker Corporation and Taubman Centers, Inc.
Mr. Parfet has been elected to a term that expires in 2011.
George H. Poste, Ph. D., D.V.M., 65, is chief executive of Health Technology Networks, a consulting group specializing in the application of genomics technologies and computing in health care. In February 2009, he assumed the post of Chief Scientist, Complex Adaptive Systems Initiative at Arizona State University. From May 2003 to February 2009, he was director of the Arizona Biodesign Institute at Arizona State University. Dr. Poste is a member of the Defense Science Board and the Health Board of the U.S. Department of Defense. He is a Fellow of the Royal Society, the Royal College of Pathologists and the UK Academy of Medicine and Distinguished Fellow at the Hoover Institution at Stanford University. Dr. Poste is also a member of the Council on Foreign Relations. He has served on the Monsanto board since February 2003. Dr. Poste chairs the Science and Technology Committee and is a member of the Public Policy and Corporate Responsibility Committee. Dr. Poste also serves on the boards of Exelixis, Inc. and Caris Holdings.
Dr. Poste has been elected to a term that expires in 2011.
Robert J. Stevens, 58, is chairman of the board and chief executive officer of Lockheed Martin Corporation, a firm engaged in the research, design, development, manufacture and integration of advanced-technology systems, products and services. During 2001 and 2002, he served on President George W. Bush's Commission to Examine the Future of the United States Aerospace Industry. Mr. Stevens has served as a director on the Monsanto board since August 2002. He chairs the board's Nominating and Corporate Governance Committee, and he is a member of the Audit and Finance Committee and of the Executive Committee. He also serves as Monsanto's lead director.
Mr. Stevens has been elected to a term that expires in 2012.
